84 related articles for article (PubMed ID: 38033363)
1. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
Manning JE; Harris E; Mathieson H; Sorensen L; Luqmani R; McGettrick HM; Morgan AW; Young SP; Mackie SL
J Autoimmun; 2024 May; 147():103260. PubMed ID: 38797046
[TBL] [Abstract][Full Text] [Related]
2. Association of clinical, imaging and laboratory parameters with adverse effects of glucocorticoid therapy in patients with giant cell arteritis.
Schweiger L; Hafner F; Meinitzer A; Brodmann M; Dejaco C; Jud P
Front Med (Lausanne); 2024; 11():1382946. PubMed ID: 38841591
[TBL] [Abstract][Full Text] [Related]
3. Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation.
Zhao SS; Mackie SL; Larsson SC; Burgess S; Yuan S
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38788669
[TBL] [Abstract][Full Text] [Related]
4. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
[TBL] [Abstract][Full Text] [Related]
5. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
6. Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank.
Chatzigeorgiou C; Taylor JC; Elliott F; O'Sullivan EP; Morgan AW; Barrett JH; Mackie SL
Rheumatol Adv Pract; 2023; 7(3):rkad095. PubMed ID: 38033363
[TBL] [Abstract][Full Text] [Related]
7. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
8. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
[TBL] [Abstract][Full Text] [Related]
10. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
11. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
Pujades-Rodriguez M; Morgan AW; Cubbon RM; Wu J
PLoS Med; 2020 Dec; 17(12):e1003432. PubMed ID: 33270649
[TBL] [Abstract][Full Text] [Related]
13. Mortality Among Patients With Polymyalgia Rheumatica: A Retrospective Cohort Study.
Partington R; Muller S; Mallen CD; Abdul Sultan A; Helliwell T
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1853-1857. PubMed ID: 32741132
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.
Wu J; Mackie SL; Pujades-Rodriguez M
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32719077
[TBL] [Abstract][Full Text] [Related]
15. Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: A case control and cohort study.
Partington R; Muller S; Mallen CD; Abdul Sultan A; Helliwell T
Semin Arthritis Rheum; 2020 Aug; 50(4):663-672. PubMed ID: 32512261
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
